SPX3,963.94-62.18 -1.54%
DIA338.49-5.03 -1.46%
IXIC11,049.50-176.86 -1.58%

--Citigroup Adjusts Price Target on Pear Therapeutics to $5 From $7, Maintains Buy Rating

--Citigroup Adjusts Price Target on Pear Therapeutics to $5 From $7, Maintains Buy Rating

MT Newswires · 11/16/2022 05:03

Please log in to view news